Emily Randall, the congresswoman representing Washington's 6th congressional district, has recently sold stocks in a range of companies, according to a congressional trade report. The transactions ...
Healthcare product and device company Abbott Laboratories (NYSE:ABT) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 7.2% year on year to $10.97 billion. Its non-GAAP profit ...
Despite being in the age of tech-stock blue-sky investing, many investors still adopt a more traditional strategy; buying shares in profitable companies like Abbott Laboratories (NYSE:ABT).
In a report released yesterday, David Toung from Argus Research maintained a Buy rating on Abbott Laboratories (ABT – Research Report). The company’s shares opened today at $129.75.
The outlook and technical action suggest Abbott Laboratories (NYSE: ABT) will lead healthcare names like Johnson & Johnson (NYSE: JNJ) higher in 2025. While each produced a solid quarter ...
She is survived by son Randall Abbott (Betty Abbott), grandchildren Brandy Hickman (Tim Hickman), Jessica Evans (Jeremy Evans), great grandchildren Hayden Hickman, Haylee Hickman, Jacob Abbott ...
In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other stocks that Jim Cramer discussed 6 months ago during his show on July 29, 2024 ...
Good morning and thank you for standing by. Welcome to Abbott’s Fourth Quarter 2024 Earnings Conference Call. All participants will be able to listen only until the question-and-answer portion ...
In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against the other stocks Jim Cramer recently talked about. Jim Cramer, the host of Mad Money ...
A year after the American Academy of Pediatrics flagged what it described as "questionable marketing practices" by makers of formulas for older infants and toddlers, Abbott Laboratories is being ...